Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 2015

View Archived Issues

Caladrius signs agreement to explore next-generation strategies for core cancer technology

City of Hope studying CAR T-cell therapy for brain cancers

Teva and Microchips Biotech partner on implantable drug delivery device

New round of funding to support Batu Biologics' development of ValloVax

Dementia Consortium funds drug discovery project in brain inflammation

Celon presents data on new PI3Kdelta inhibitor

First-in-human results reported for MLN-1117 in patients with solid tumors

Final data confirm benefit of imeglimin in phase IIb diabetes trial

Results for CR-6086 in preclinical models of rheumatoid arthritis

Kite Pharma and bluebird bio to advance second-generation TCR cell therapy products

Forum Pharmaceuticals' encenicline receives FDA fast track designation

Fujifilm updates development of radiopharmaceuticals for neuroendocrine tumors

3SBio acquires global rights to anti-TNF MAb

New AAV-based gene therapy presented for the treatment of brain arteriovenous malformation

Ampio Pharmaceuticals reports additional data for Optina in diabetic macular edema

IOmet Pharma patents IDO/TDO inhibitors

Bayer Schering Pharma describes GnRH receptor antagonists

University of Illinois and the Hong Kong Baptist University report anticancer maytansinoids

Allergan develops CCR2 antagonists

Team in Israel presents RNA polymerase I inhibitors

OphthaliX to acquire Improved Vision Systems

Kythera launches Kybella in U.S.

Pfizer to acquire Nimenrix and Mencevax from GSK

FDA approves Kengreal as adjunctive to PCI for reducing thrombotic events

Vaxil's ImMucin designated FDA orphan drug for multiple myeloma

Isis reports findings from extension study of ISIS-SMNRx in spinal muscular atrophy

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...